[Clinical and sero-immunologic results of therapeutic trials of Ciba 32'644 Ba, carried out in 350 patients with chronic Schistosoma haematobium and Schistosoma mansoni bilharziasis].
D000293:Adolescent; D000328:Adult; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D001773:Blood Cells / Q000187:drug effects; D002648:Child; D004064:Digestive System / Q000187:drug effects; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009420:Nervous System / Q000187:drug effects; D011605:Psychoses, Substance-Induced / Q000209:etiology; D012552:Schistosomiasis / Q000188:drug therapy*; D001745:Urinary Bladder Diseases / Q000188:drug therapy*
D000871:Anthelmintics
Résultats cliniques et séro-immunologiques des essais thérapeutiques par le Ciba 32'644 Ba, portant sur 350 bilharziens chroniques à Schistosoma haematobium et Schistosoma mansoni.